Is mitral regurgitation a recognized complication of dengue infection?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 17, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Mitral Regurgitation is NOT a Recognized Primary Complication of Dengue

Mitral regurgitation is not listed among the established cardiac complications of dengue infection. The most frequent cardiac manifestations of dengue are arrhythmias, pericarditis, myocarditis, and deterioration in myocardial function—not valvular disease 1.

Recognized Cardiac Complications of Dengue

According to the most recent 2025 European guidelines on cardiac imaging in tropical diseases, cardiac involvement in dengue occurs in 12-50% of hospitalized patients and includes 1:

  • Arrhythmias (most common)
  • Pericarditis and pericardial effusion
  • Myocarditis with LV systolic dysfunction
  • Deterioration in myocardial function
  • Rare complications: myocardial infarction, coronary dissection, intramural hematoma

Recent research confirms these findings, with a 2026 cross-sectional study of 919 dengue patients showing pericardial effusion (26%), elevated troponin (38%), and ECG abnormalities (10%)—but no mention of mitral regurgitation as a complication 2.

Important Clinical Context

When Mitral Regurgitation Appears with Dengue

The evidence shows mitral regurgitation occurring in dengue patients only in these specific scenarios:

  1. Pre-existing mitral valve disease: A 2025 case report described dengue myocarditis in a patient who already had prosthetic mitral and aortic valves from prior valve replacement 3

  2. Secondary infective endocarditis: A 2026 case report documented dengue-related immunosuppression leading to secondary bacterial infective endocarditis with mitral valve vegetation and resultant mitral regurgitation 4

These represent complications OF complications—not direct dengue-related valvular pathology.

Clinical Pitfalls to Avoid

  • Do not attribute new mitral regurgitation directly to dengue infection—look for alternative explanations including pre-existing valve disease or secondary bacterial endocarditis

  • Dengue-associated immunosuppression can predispose to secondary bacterial infections, including infective endocarditis 4

  • Cardiac involvement in dengue is significantly underdiagnosed in endemic areas, with only a small percentage of patients receiving cardiac evaluation 1

  • Any echocardiographic abnormality in dengue is associated with adverse outcomes 1, so cardiac assessment should be performed in high-risk patients

Who Needs Cardiac Evaluation in Dengue

Based on 2026 research identifying predictors of cardiac involvement 2:

  • Age >60 years
  • Presence of warning signs
  • Anemia
  • Thrombocytopenia
  • Elevated serum creatinine
  • Hypoalbuminemia
  • Elevated D-dimer levels

Echocardiography should be performed in patients with ECG abnormalities, hemodynamic instability, or elevated cardiac biomarkers 5.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.